Bexarotene prodrugs: Targeting through cleavage by NQO1 (DT-diaphorase)

被引：14

作者：

Schafer, Anja ^{[1
]}

Burstein, Ethan S. ^{[2
]}

Olsson, Roger ^{[1
,2
,3
]}

机构：

[1] Univ Gothenburg, Dept Chem & Mol Biol Med Chem, SE-41296 Gothenburg, Sweden

[2] ACADIA Pharmaceut Inc, San Diego, CA 92121 USA

[3] Lund Univ, Dept Expt Med Sci, SE-22184 Lund, Sweden

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2014年 / 24卷 / 08期

关键词：

Prodrugs; Parkinson's disease; Alzheimer's disease; dt diaphorase; Disease targeting; Bexarotene; INDOLEQUINONE ANTITUMOR AGENTS; NAD(P)H-QUINONE OXIDOREDUCTASE; QUINONE STRUCTURE; METABOLISM; ACTIVATION; DOPAMINE; EXPRESSION; MECHANISM; DESIGN; ELIMINATION;

D O I：

10.1016/j.bmcl.2014.03.003

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Bexarotene, a retinoid X receptor (RXR) agonist, is being tested as a potential disease modifying treatment for neurodegenerative conditions. To limit the peripheral exposure of bexarotene and release it only in the affected areas of the brain, we designed a prodrug strategy based on the enzyme NAD( P) H/quinone oxidoreductase (NQO1) that is elevated in neurodegenerative diseases. A series of indolequinones (known substrates of NQO1) was synthesized and coupled to bexarotene. Bexarotene-3(hydroxymethyl)-5-methoxy-1,2-dimethyl-1H-indole-4,7-dione ester 7a was cleaved best by NQO1. The prodrugs are not cleaved by esterase. (C) 2014 Elsevier Ltd. All rights reserved.

引用

页码：1944 / 1947

页数：4

共 50 条

[41] Studies of pyrrolo[1,2-a]benzimidazolequinone DT-diaphorase substrate activity, topoisomerase II inhibition activity, and DNA reductive alkylation
Skibo, EB
Gordon, S
Bess, L
Boruah, R
Heileman, MJ
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (09) : 1327 - 1339
[42] PURIFIED RAT-LIVER DT-DIAPHORASE POTENTIATES THE MUTAGENICITY OF 1,3-DINITROPYRENE, 1,6-DINITROPYRENE AND 1,8-DINITROPYRENE
HAJOS, AKD
WINSTON, GW
FASEB JOURNAL, 1991, 5 (04): : A882 - A882
[43] Targeting NQO1/GPX4-mediated ferroptosis by plumbagin suppresses in vitro and in vivo glioma growth
Zhan, Sheng
Lu, Li
Pan, Shu-shan
Wei, Xiao-qian
Miao, Rong-rong
Liu, Xiao-hui
Xue, Ming
Lin, Xiu-kun
Xu, Huan-li
BRITISH JOURNAL OF CANCER, 2022, 127 (02) : 364 - 376
[44] The importance of DT-diaphorase and hypoxia in the cytotoxicity of RH1 in human breast and non-small cell lung cancer cell lines
Kim, JY
Patterson, AV
Stratford, IJ
Hendry, JH
ANTI-CANCER DRUGS, 2004, 15 (01) : 71 - 77
[45] Targeting NQO1/GPX4-mediated ferroptosis by plumbagin suppresses in vitro and in vivo glioma growth
Sheng Zhan
Li Lu
Shu-shan Pan
Xiao-qian Wei
Rong-rong Miao
Xiao-hui Liu
Ming Xue
Xiu-kun Lin
Huan-li Xu
British Journal of Cancer, 2022, 127 : 364 - 376
[46] Effect of dicumarol, a NAD(P)H: Quinone acceptor oxidoreductase 1 (DT-diaphorase) inhibitor on ubiquinone redox cycling in cultured rat hepatocytes
Kishi, T
Takahashi, T
Mizobuchi, S
Mori, K
Okamoto, T
FREE RADICAL RESEARCH, 2002, 36 (04) : 413 - 419
[47] Targeting NAD(P)H:quinone oxidoreductase 1 (NQO1) in pancreatic ductal adenocarcinoma: An in silco, in vitro and in vivo approach
Ganji, Purnachandra N.
Lesinski, Gregory B.
El-Rayes, Bassel F.
CANCER RESEARCH, 2022, 82 (12)
[48] DT-DIAPHORASE ACTIVITY AND THE CYTO-TOXICITY OF QUINONES IN C3H-10T1/2 MOUSE EMBRYO CELLS
ATALLAH, AS
LANDOLPH, JR
ERNSTER, L
HOCHSTEIN, P
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (12) : 2451 - 2459
[49] Design and synthesis of NAD(P)H: Quinone oxidoreductase (NQO1)-activated prodrugs of 23-hydroxybetulinic acid with enhanced antitumor properties
Zhu, Huajian
Lu, Lixue
Zhu, Wenjian
Tan, Yuchen
Duan, Yiping
Liu, Jie
Ye, Wencai
Zhu, Zheying
Xu, Jinyi
Xu, Shengtao
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 240
[50] Construction of Dual Stimuli-Responsive Platinum(IV) Hybrids with NQO1 Targeting Ability and Overcoming Cisplatin Resistance
Fang, Lei
Qin, Xiaodong
Zhao, Jian
Gou, Shaohua
INORGANIC CHEMISTRY, 2019, 58 (03) : 2191 - 2200

← 1 2 3 4 5 →